Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
Cholangiocarcinoma is characterized by a poor prognosis with limited treatment and management options. Chemotherapy using gemcitabine with cisplatin is the only available first-line therapy for patients with advanced cholangiocarcinoma, although it offers only palliation and yields a median survival...
Main Authors: | Xianzhe Yu, Lingling Zhu, Ting Wang, Jiang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1037945/full |
Similar Items
-
Immunotherapy in cholangiocarcinoma: From concept to clinical trials
by: Wen-Yan Yao, et al.
Published: (2021-06-01) -
Immune microenvironment and progress in immunotherapy of cholangiocarcinoma
by: Xinyu Shao
Published: (2023-12-01) -
Heterogeneity of the tumor immune microenvironment and its clinical relevance
by: Qingzhu Jia, et al.
Published: (2022-04-01) -
Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy
by: Lara Heij, et al.
Published: (2023-03-01) -
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
by: Florent Petitprez, et al.
Published: (2020-05-01)